144 related articles for article (PubMed ID: 37057942)
21. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
[TBL] [Abstract][Full Text] [Related]
23. [Immunophenotypic Analysis of Acute Promyelocytic Leukemia].
Chen F; Hu YP; Wang XH; Fu S; Fu Y; Liu X; Zhang MY; Wang SK; Zhang JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):321-5. PubMed ID: 27150985
[TBL] [Abstract][Full Text] [Related]
24. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
25. Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells.
Liu X; Sun W; Wang L; Zhou B; Li P
Bull Cancer; 2023 Apr; 110(4):342-351. PubMed ID: 36863921
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
[TBL] [Abstract][Full Text] [Related]
28. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
[TBL] [Abstract][Full Text] [Related]
29. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS
Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous occurrence of biphenotypic T cell/myeloid lesions involving t(12;13)(p13;q14) in a pediatric patient.
Carneiro Borba C; de Lourdes Chauffaille M; Saeed Sanabani S; Saeed Sanabnai S; Folloni Fernandes J; Aiko Kumeda C; Rodrigues Pereira Velloso ED; Jarandilha dos Santos K; Puato Vieira Pupim M; Hamerschlak N; Odone Filho V; Bendit I
Acta Haematol; 2012; 127(3):165-9. PubMed ID: 22301888
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
[TBL] [Abstract][Full Text] [Related]
32. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
33. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia.
De J; Zanjani R; Hibbard M; Davis BH
Am J Clin Pathol; 2007 Oct; 128(4):550-7. PubMed ID: 17875504
[TBL] [Abstract][Full Text] [Related]
36. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.
de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA
Mol Cell Biol; 2002 Aug; 22(15):5506-17. PubMed ID: 12101243
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of immunophenotypes and expressions of non-myeloid antigens in acute myeloid leukemia].
Wang W; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1639-1644. PubMed ID: 33243747
[TBL] [Abstract][Full Text] [Related]
39. FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1-ETO and PML-RARA.
Chen M; Fu M; Wang A; Wu X; Zhen J; Gong M; Wu P; Du Q; Wang T; Liu H; Wang H
Int J Lab Hematol; 2021 Dec; 43(6):e276-e279. PubMed ID: 33943002
[No Abstract] [Full Text] [Related]
40. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Bradstock K; Matthews J; Benson E; Page F; Bishop J
Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
